Your browser doesn't support javascript.
loading
mTOR inhibitors in urinary bladder cancer.
Pinto-Leite, R; Arantes-Rodrigues, R; Sousa, Nuno; Oliveira, P A; Santos, L.
Affiliation
  • Pinto-Leite R; Genetic Service, Cytogenetic Laboratory, Hospital Center of Trás-os-Montes and Alto Douro, Vila Real, Portugal. MLLEITE@chtmad.min-saude.pt.
  • Arantes-Rodrigues R; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, Porto, Portugal. MLLEITE@chtmad.min-saude.pt.
  • Sousa N; Centre for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), University of Trás-os-Montes and Alto Douro, Vila Real, Portugal.
  • Oliveira PA; QOPNA, Mass Spectrometry Center, Department of Chemistry, University of Aveiro, Aveiro, Portugal.
  • Santos L; Institute for Research and Innovation in Health (I3S), Porto, Portugal.
Tumour Biol ; 37(9): 11541-11551, 2016 Sep.
Article in En | MEDLINE | ID: mdl-27235118
Subject(s)
Key words
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / TOR Serine-Threonine Kinases Limits: Animals / Humans Language: En Journal: Tumour Biol Journal subject: NEOPLASIAS Year: 2016 Document type: Article Affiliation country: Portugal Country of publication: Netherlands
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / TOR Serine-Threonine Kinases Limits: Animals / Humans Language: En Journal: Tumour Biol Journal subject: NEOPLASIAS Year: 2016 Document type: Article Affiliation country: Portugal Country of publication: Netherlands